tiprankstipranks
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
Holding ALGS?
Track your performance easily

Aligos Therapeutics (ALGS) Ownership - Who Owns Aligos Therapeutics?

163 Followers

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$719256
Sep 30, 2024
xxxxxxxxxxxxx
$796468

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,120,633Insider61.22%84,486,019
1,457,937Institution42.09%58,084,210
394,064Insider11.38%15,699,510
183,083Insider5.29%7,294,027
91,971Institution2.65%3,664,125
83,055Institution2.40%3,308,911
63,814Institution1.84%2,542,350
63,814Institution1.84%2,542,350
18,783Institution0.54%748,315
14,196Institution0.41%565,569

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
63,814Institution1.84%2,542,350
14,196Institution0.41%565,569
3,248Institution0.09%129,400

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
52,795Institution1.52%516,335
10,730Institution0.31%411,496
11,019Institution0.32%107,766
56Institution<0.01%2,148
125Institution<0.01%114

FAQ

Who Owns Aligos Therapeutics (ALGS)?
Currently, no data Available
What percentage of Aligos Therapeutics (ALGS) stock is held by institutional investors?
Currently, no data Available
What percentage of Aligos Therapeutics (ALGS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Aligos Therapeutics (ALGS)?
LAWRENCE BLATT owns the most shares of Aligos Therapeutics (ALGS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis